Pharmaceutical and medical device companies operating in the U.S. must comply with strict Good Manufacturing Practices (GMPs) to ensure public safety, efficacy, and product quality. Yet, despite rigorous internal controls, …

Sia/LBG’s Andrew B. Harmon, a recognized subject matter expert providing strategic insights across the biopharmaceutical industry, recently presented a forward-looking model for the viral vector market at BioProcess International Europe …